Original research
par
Meyerson, Beth E. et al
Date de publication
2022
Géographie
USA
Langue de la ressource
English
Texte disponible en version intégrale
Oui
Open Access / OK to Reproduce
Oui
Évalué par des pairs
Yes
L’objectif
To understand patient experience of federal regulatory changes governing methadone and buprenorphine (MOUD) access in Arizona during the COVID-19 pandemic.
Constatations/points à retenir
MOUD patients in Arizona were not offered many of the federally allowed flexibilities for access that were designed to reduce their need to be at the clinic. All participants expressed that daily clinic visits interrupted their work and home lives and desired more take-home dosing and home delivery options.
La conception ou méthodologie de recherche
Interviews (n=131)
Mots clés
Policy/Regulatory
About PWUD
Substitution/OAT
Carries/take-home doses
